Use of Corticosteroid-Eluting Sinus Stents Between 2012 and 2017

JAMA Otolaryngol Head Neck Surg. 2019 Jan 1;145(1):90-91. doi: 10.1001/jamaoto.2018.2944.

Authors

Shekhar K Gadkaree^{1

2}, Vinay K Rathi^{1

3}, George A Scangas^{1

2}, Matthew R Naunheim^{1

2}, Ralph Metson^{1

2}

Affiliations

¹ Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston.
² Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.
³ Harvard Business School, Boston, Massachusetts.

Abstract

This study characterizes the extent and cost of the use of corticosteroid-eluting sinus stents between 2012 and 2017.

Publication types

Letter

MeSH terms

Absorbable Implants
Anti-Inflammatory Agents / administration & dosage*
Anti-Inflammatory Agents / economics
Anti-Inflammatory Agents / therapeutic use
Cost-Benefit Analysis
Drug-Eluting Stents* / economics
Drug-Eluting Stents* / statistics & numerical data
Health Care Costs / statistics & numerical data
Humans
Mometasone Furoate / administration & dosage*
Mometasone Furoate / economics
Mometasone Furoate / therapeutic use
Nasal Obstruction / economics
Nasal Obstruction / etiology
Nasal Obstruction / prevention & control
Paranasal Sinuses / surgery*
Postoperative Care / economics
Postoperative Care / methods*
Postoperative Care / statistics & numerical data
Postoperative Complications / economics
Postoperative Complications / prevention & control
Practice Patterns, Physicians' / economics
Practice Patterns, Physicians' / trends*
Procedures and Techniques Utilization / economics
Procedures and Techniques Utilization / trends*
Tissue Adhesions / economics
Tissue Adhesions / etiology
Tissue Adhesions / prevention & control
United States

Substances

Anti-Inflammatory Agents
Mometasone Furoate